Skip to main content
. 2021 Jan 29;2021(1):CD013496. doi: 10.1002/14651858.CD013496.pub2

NCT03805776.

Study name Intermittent fasting in dyslipidemia
Methods Randomised controlled trial
Participants 60 participants. Ages Eligible for Study: 18 years to 80 years (adult, older adult)
Sexes Eligible for Study: all
Accepts Healthy volunteers: yes
Inclusion Criteria
General population with serum HDL less than 40 mg/dL for men and women
Adult ages 18‐ 80 years will be included in the study.
Interventions Experimental: interventional
Will observe intermittent fasting
Other: fasting (diet restriction for specific period)
12‐14 hours fasting
No Intervention: control
Outcomes Primary Outcome Measures :
Lipid profile [ Time Frame: 6 weeks ]
Change in HDL more than 3mg/dL Change in LDL more than 3mg/dl Cholesterol and TG
weight loss [ Time Frame: 6 weeks ]
Change in body weight (kg), as measured by scale weight
Blood pressure [ Time Frame: 6 weeks ]
Reduction in systolic and diastolic
Secondary Outcome Measures:
Fasting Glucose [ Time Frame: 6 weeks ]
Fasting glucose mg/dl
Fasting Insulin [ Time Frame: 6 weeks ]
Fasting insulin (IU/L)
Waist circumference Waist circumference (cm) [ Time Frame: 6 weeks ]
WC in cm
Lipid profile HbA1c (%) Lipids [ Time Frame: 6 weeks ]
Total cholesterol (mg/dl), LDL cholesterol (mg/dl), HDL cholesterol (mg/dl), and triglycerides (mg/dl)
Waist circumference [ Time Frame: 6 weeks ]
Waist circumference (cm)
Starting date February 20, 2019
Contact information javeria.farooq@aku.edu
Notes NCT03805776